BMY Gets Positive CHMP Opinion for Opdivo, Yervoy Combo and Breyanzi
The CHMP recommends approval of Bristol Myers' Opdivo plus Yervoy for the first-line treatment of hepatocellular carcinoma ...
Cancer Survivor, 25, Shares Powerful Reminder for Those Facing a Diagnosis
Cancer survivor Zoe Plastiras hopes her message provides some reassurance by highlighting advances in cancer treatment.
Le Lézard10d
Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma
Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...
Frontiers17d
Case Report: A crushing sensation—a rare case of mediastinal germ cell tumor causing cardiac tamponade
A chest computed tomography (CT) was remarkable for a large anterior mediastinal mass abutting the pericardium, which was deemed to most likely represent a germ cell tumor, although lymphoma could not ...
Reuters22d
Mugshot, khaki uniform and solitary cell for South Korea's detained President Yoon
Yoon "spent the night well," Shin said. After he was processed, Yoon was moved to the general detention section where he was allocated a solitary cell measuring about 12 square metres (129 square ...
Pharmaceutical Technology23d
Pembrolizumab by Merck for Recurrent Glioblastoma Multiforme (GBM): Likelihood of Approval
It is also under development for paraganglioma and pheochromocytoma as second line therapy It was also under development for the treatment of primary mediastinal large B cell lymphoma, metastatic ...
Everyday Health25d
Stage 4 Lymphoma
Kinase Inhibitors These drugs block certain enzymes that control cell growth, helping to keep lymphoma cells from growing. Targeted therapy drugs may have side effects. The types of side effects ...
Frontiers26d
Pericardial mesothelioma mimicking mediastinal lymphoma and systemic rheumatic disease: a case report
Cell atypia of ... of mesothelioma included a large pericardial effusion, noticeable pericardial thickening, and mediastinal lymphadenopathy, observed alongside the exclusion of more common causes, ...
Medical Xpress28d
Clinical trial: Off-the-shelf immunotherapy shows promise for B-cell lymphoma
"For patients with large B-cell lymphoma who undergo FDA-approved CAR-T cell therapy, approximately 60% experience a relapse. These patients have very limited treatment options, and most survive ...
BioSpace28d
CAR T Cell Therapy Breyanzi® (lisocabtagene maraleucel) Approved for Second-Line Relapsed or Refractory Diffuse Large B-cell Lymphoma
Breyanzi ® offers diffuse large B-cell lymphoma patients facing relapse or refractory disease earlier access with more personalized second-line treatment options. In the pivotal Phase 3 TRANSFORM ...
MedPage Today29d
CAR Natural Killer Cell Therapy Shows Promise in B-Cell Lymphomas
Among 11 patients with large B-cell lymphomas other than de novo diffuse large B-cell lymphoma, objective response and complete response rates were 82% and 64%. Moreover, patients who had ...